Laporan Laba Rugi ANIP - TTM - ANI Pharmaceuticals, Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi ANI Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	199	208	213	213	212	216	226	251	283	316	359	401	449	487	517	539	555	614	674	747
Change (%)		4.66	2.28	0.07	-0.43	1.73	4.61	11.16	12.64	11.76	13.37	11.90	11.96	8.33	6.29	4.15	3.06	10.61	9.72	10.88
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	80	87	88	91	91	101	115	123	131	139	137	149	164	182	193	208	223	250	274	291
Change (%)		8.39	1.01	3.43	0.21	10.26	14.20	7.12	6.48	5.90	-1.34	8.61	10.56	10.40	6.31	7.99	7.19	12.03	9.54	6.17
% of Revenue	40.37	41.81	41.29	42.67	42.95	46.55	50.82	48.97	46.30	43.87	38.17	37.05	36.59	37.29	37.29	38.66	40.21	40.73	40.66	38.94

Gross Operating Profit	119	121	125	122	121	116	111	128	152	178	222	253	285	305	324	331	332	364	400	456
Change (%)		2.14	3.19	-2.29	-0.91	-4.69	-3.75	15.33	18.54	16.82	24.87	13.93	12.78	7.13	6.29	1.87	0.46	9.65	9.83	14.10
% of Revenue	59.63	58.19	58.71	57.33	57.05	53.45	49.18	51.03	53.70	56.13	61.83	62.95	63.41	62.71	62.71	61.34	59.79	59.27	59.34	61.06

SG&A	65	65	62	66	61	84	86	99	112	124	122	129	141	162	173	184	212	237	265	298
Change (%)		0.54	-3.99	6.58	-7.59	37.17	2.17	15.25	13.00	10.59	-1.41	5.56	9.24	14.66	7.14	6.10	15.38	11.86	11.64	12.59
% of Revenue	32.45	31.17	29.26	31.16	28.92	39.00	38.09	39.50	39.62	39.21	34.09	32.16	31.38	33.22	33.48	34.11	38.18	38.61	39.29	39.90

R&D	17	16	13	16	12	11	14	15	20	22	23	26	30	34	39	39	38	45	45	54
Change (%)		-5.85	-21.10	28.28	-26.45	-4.56	20.28	9.95	34.59	10.29	2.91	13.97	13.23	15.67	13.38	-0.20	-2.56	17.93	0.12	20.70
% of Revenue	8.53	7.68	5.92	7.59	5.61	5.26	6.05	5.98	7.15	7.05	6.40	6.52	6.60	7.04	7.51	7.20	6.81	7.26	6.62	7.21

OpEx	220	224	214	222	213	244	266	291	320	342	339	362	394	437	465	491	534	600	660	728
Change (%)		1.78	-4.44	3.60	-4.04	14.78	9.02	9.24	9.86	7.04	-0.82	6.70	8.88	10.94	6.31	5.57	8.72	12.41	9.96	10.32
% of Revenue	110.51	107.47	100.41	103.95	100.18	113.03	117.81	115.77	112.91	108.13	94.59	90.19	87.71	89.83	89.84	91.06	96.06	97.62	97.84	97.35

Operating Income	-21	-16	-1	-8	-0	-28	-40	-40	-37	-26	19	39	55	50	53	48	22	15	15	20
Change (%)		-25.66	-94.33	854.59	-95.34	7,067.68	42.91	-1.56	-7.78	-29.58	-175.36	102.94	40.32	-10.32	6.20	-8.39	-54.55	-33.25	-0.36	35.98
% of Revenue	-10.51	-7.47	-0.41	-3.95	-0.18	-13.03	-17.81	-15.77	-12.91	-8.13	5.41	9.81	12.29	10.17	10.16	8.94	3.94	2.38	2.16	2.65

Interest Expense	-10	-9	-14	-14	-14	-12	-21	-25	-30	-28	-32	-33	-34	-35	-36	-37	-32	-33	-32	-31
Change (%)		-4.87	45.42	1.22	-0.09	-14.31	75.04	19.91	19.52	-5.17	12.67	3.88	2.76	2.54	3.37	2.41	-14.21	4.11	-3.00	-2.30
% of Revenue	-5.00	-4.55	-6.46	-6.54	-6.56	-5.53	-9.25	-9.98	-10.59	-8.98	-8.93	-8.29	-7.61	-7.20	-7.00	-6.88	-5.73	-5.39	-4.77	-4.20

Net Income	-24	-23	-15	-17	-22	-43	-63	-64	-68	-48	-26	-5	13	19	36	27	-7	-19	-21	-10
Change (%)		-5.05	-31.48	11.46	28.34	92.76	47.45	1.30	6.53	-29.35	-45.03	-80.40	-359.37	40.34	89.29	-24.00	-126.25	161.20	13.64	-51.48
% of Revenue	-11.92	-10.82	-7.25	-8.07	-10.40	-19.71	-27.78	-25.32	-23.95	-15.14	-7.34	-1.29	2.98	3.86	6.87	5.01	-1.28	-3.01	-3.12	-1.37

Source: Capital IQ

ANI Pharmaceuticals, Inc. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings